Literature DB >> 9413706

Metrifonate.

H M Lamb1, D Faulds.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9413706     DOI: 10.2165/00002512-199711060-00008

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


× No keyword cloud information.
  19 in total

1.  Effect of metrifonate on extracellular brain acetylcholine and object recognition in aged rats.

Authors:  C Scali; M G Giovannini; L Bartolini; C Prosperi; V Hinz; B Schmidt; G Pepeu
Journal:  Eur J Pharmacol       Date:  1997-05-01       Impact factor: 4.432

2.  Double-blind, placebo-controlled study of metrifonate, an acetylcholinesterase inhibitor, for Alzheimer disease.

Authors:  R E Becker; J A Colliver; S J Markwell; P L Moriearty; L K Unni; S Vicari
Journal:  Alzheimer Dis Assoc Disord       Date:  1996       Impact factor: 2.703

3.  Pharmacokinetics and pharmacodynamics of metrifonate in humans.

Authors:  L K Unni; C Womack; M E Hannant; R E Becker
Journal:  Methods Find Exp Clin Pharmacol       Date:  1994-05

4.  Effect of metrifonate on neuromuscular transmission.

Authors:  P M Le Quesne; I C Maxwell
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1981

5.  Effects of metrifonate on escape and avoidance learning in young and aged rats.

Authors:  F.J. van Der Staay; V.C. Hinz; B.H. Schmidt
Journal:  Behav Pharmacol       Date:  1996-01       Impact factor: 2.293

6.  Effects of combined chronic nimodipine and acute metrifonate treatment on spatial and avoidance behavior.

Authors:  M Riekkinen; B Schmidt; J Kuitunen; P Riekkinen
Journal:  Eur J Pharmacol       Date:  1997-03-12       Impact factor: 4.432

7.  Metrifonate effects on acetylcholine and biogenic amines in rat cortex.

Authors:  F Mori; G Cuadra; E Giacobini
Journal:  Neurochem Res       Date:  1995-09       Impact factor: 3.996

8.  Stability of peripheral hematological parameters after chronic acetylcholinesterase inhibition in man.

Authors:  P L Moriearty; C L Womack; B W Dick; J A Colliver; R S Robbs; R E Becker
Journal:  Am J Hematol       Date:  1991-08       Impact factor: 10.047

9.  A comparison of the effects of two inhibitors on brain cholinesterase.

Authors:  M Hallak; E Giacobini
Journal:  Neuropharmacology       Date:  1987-06       Impact factor: 5.250

10.  Levels of metrifonate and dichlorvos in plasma and erythrocytes during treatment of schistosomiasis with Bilarcil.

Authors:  I Nordgren; E Bengtsson; B Holmstedt; B M Pettersson
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1981
View more
  2 in total

Review 1.  Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology.

Authors:  A Nordberg; A L Svensson
Journal:  Drug Saf       Date:  1998-12       Impact factor: 5.606

Review 2.  Cholinesterase inhibitors for the treatment of Alzheimer's disease in the elderly.

Authors:  C M VanDenBerg; Y Kazmi; M W Jann
Journal:  Drugs Aging       Date:  2000-02       Impact factor: 3.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.